China Medical Device Authority Restructured as NMPA

In March 2018, China restructured the medical device authority from China Food and Drug Administration (Known as CFDA) to National Medical Products Administration(Known as NMPA), it is administered by the State Administration for Market Regulation (Known as SAMR).

The new name NMPA shall be adapted from 1st September 2018, it has been changed ‘CFDA’ to ‘NMPA’ in the medical device registration and approval system. Any registrants need to use the new name and its abbreviation of the China medical device authorities during the medical device registration in China.

Contact Us
CIRS China

Ms. Shuo Wang (Head office)
Tel: +86-571 8720 6559 | Fax: +86-571 87206533
Email: md@cirs-group.com
Mr. Edwin Wen (Beijing office)
Tel: +86-10 63984062 | Fax: +86-10 63984032
Email: md@cirs-group.com

CIRS Europe

Ms. Louise Halpin
Tel: +353 41 9806 916 | Fax: +353 41 9806 999
Email: md@cirs-group.com